MarketPeel
Insider Trading Intelligence
VL

Vivo Opportunity, Llc

TERN
10% OWNER · TERNS PHARMACEUTICALS, INC. · CIK 0001728970
FILING MIX · LIFETIME44%/56%
BUYS
56
SELLS
71
TOTAL VALUE
$306.76M
COMPANIES
7
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
16,145,430
AVG SELL PX
$50.71
TRADE KIND
SHOWING 127 / 127
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
59 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by Vivo Opportunity, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d59+45.76%-0.56%-0.62%+0.06%-0.38%0.03
14d59+45.76%-2.65%-1.49%-1.16%-2.09%-0.54
30d59+76.27%+0.73%-3.47%+4.20%+2.24%1.40
60d59+62.71%-3.29%-4.73%+1.44%-12.06%0.38
90d59+50.85%-0.55%+0.74%-1.30%-2.28%-0.42
180d59+71.19%+7.84%+9.06%-1.22%-26.45%-0.15
1y59+79.66%-21.75%+18.66%-40.41%-50.43%-6.75
2y59(6 pending)+60.38%+103.81%+37.55%+66.26%-56.42%1.70
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TERN · 4,023,741 shares · as of Apr 3, 2024
01,085,0532,170,1063,255,1594,340,212202220232024SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 56 buys / 71 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INM
INMED PHARMACEUTICALS INC.
PURCHASE
1,460$1.55$2.3K724,395Jul 2, 2026Jul 2, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
147$1.55$22873,135Jul 2, 2026Jul 2, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
398$1.55$61772,988Jul 1, 2026Jul 2, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
3,946$1.55$6.1K722,935Jul 1, 2026Jul 2, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
545$1.54$839718,989Jun 30, 2026Jul 2, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
55$1.54$8572,590Jun 30, 2026Jul 2, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
29,518$1.52$44.9K718,444Jun 8, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
2,982$1.52$4.5K72,535Jun 8, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
49,966$1.57$78.4K688,926Jun 5, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
5,045$1.57$7.9K69,553Jun 5, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
6,125$1.57$9.6K638,960Jun 4, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
618$1.57$97064,508Jun 4, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
7,069$1.55$11.0K632,835Jun 3, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
714$1.55$1.1K63,890Jun 3, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
2,095$1.52$3.2K63,176Jun 2, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
20,753$1.52$31.5K625,766Jun 2, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
14,838$1.55$23.0K605,013Jun 1, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
1,498$1.55$2.3K61,081Jun 1, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
1,632$1.57$2.6K59,583May 29, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
16,164$1.57$25.4K590,175May 29, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
3,118$1.69$5.3K57,951May 21, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
30,882$1.69$52.2K574,011May 21, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
5,154$1.56$8.0K54,833May 20, 2026Jun 10, 2026View →
INM
INMED PHARMACEUTICALS INC.
PURCHASE
51,056$1.56$79.6K543,129May 20, 2026Jun 10, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
333,557$70.60$23.55M4,458,294Mar 28, 2025Mar 28, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
1,100,000$67.80$74.58M4,791,851Mar 27, 2025Mar 28, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
400,000$65.80$26.32M5,891,851Mar 26, 2025Mar 28, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
100,000$47.22$4.72M6,291,851Aug 29, 2024Aug 29, 2024View →
SLNO
SOLENO THERAPEUTICS INC
SALE
425,000$47.35$20.12M6,391,851Aug 28, 2024Aug 29, 2024View →
SLNO
SOLENO THERAPEUTICS INC
SALE
500,000$48.73$24.36M6,816,851Aug 27, 2024Aug 29, 2024View →
SLNO
SOLENO THERAPEUTICS INC
SALE
351,242$45.13$15.85M7,316,851Apr 30, 2024May 1, 2024View →
SLNO
SOLENO THERAPEUTICS INC
SALE
750,000$47.80$35.85M7,668,093Apr 29, 2024May 1, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,149$6.20$25.7K268,573Apr 3, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
30,047$6.20$186.3K1,945,015Apr 3, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
103,870$6.20$644.0K4,023,741Apr 3, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
22,084$6.65$146.9K1,975,062Apr 2, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,050$6.65$20.3K272,722Apr 2, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
76,346$6.65$507.7K4,127,611Apr 2, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,451$6.99$38.1K275,772Apr 1, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
39,411$6.99$275.5K1,997,146Apr 1, 2024Apr 3, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
136,255$6.99$952.4K4,203,957Apr 1, 2024Apr 3, 2024View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,457$0.90$1.3K111,662Nov 21, 2023Nov 22, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,707$0.90$1.5K1,952,302Nov 21, 2023Nov 22, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
236$0.90$212269,587Nov 21, 2023Nov 22, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
3,792$0.92$3.5K269,823Nov 20, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
27,465$0.92$25.3K1,954,009Nov 20, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
23,443$0.92$21.6K113,119Nov 20, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,134$0.93$1.1K273,615Nov 17, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
8,211$0.93$7.6K1,981,474Nov 17, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
7,009$0.93$6.5K136,562Nov 17, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
7,531$0.96$7.2K1,989,685Nov 16, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,040$0.96$998274,749Nov 16, 2023Nov 20, 2023View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
6,429$0.96$6.2K143,571Nov 16, 2023Nov 20, 2023View →
SLNO
SOLENO THERAPEUTICS INC
SALE
5,215,0000Oct 2, 2023Oct 4, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
5,215,000$2.50$13.04M8,418,093Oct 2, 2023Oct 4, 2023View →
SLNO
SOLENO THERAPEUTICS INC
SALE
3,203,0930Sep 26, 2023Sep 28, 2023View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
3,203,093$1.75$5.61M3,203,093Sep 26, 2023Sep 28, 2023View →
IOBT
IO BIOTECH, INC.
PURCHASE
3,157,894$0.13$394.7K3,157,894Aug 9, 2023Aug 10, 2023View →
IOBT
IO BIOTECH, INC.
PURCHASE
3,157,894$1.90$6.00M3,157,894Aug 9, 2023Aug 10, 2023View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
758,620$7.25$5.50M4,340,212Dec 23, 2022Dec 23, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
600,000$3.60$2.16M3,581,592Sep 7, 2022Sep 8, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,500,000$2.42$3.63M2,981,592Aug 16, 2022Aug 16, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,500,000$2.42$3.63M1,500,000Aug 16, 2022Aug 16, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,218$2.99$3.6K1,481,592Aug 15, 2022Aug 16, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,123,021$2.98$3.35M1,480,374Aug 12, 2022Aug 16, 2022View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
944,056958,341Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
24,267$20.00$485.3K275,789Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
175,733$20.00$3.51M1,997,216Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
317,9221,435,106Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
17,711$0.07$1.2K1,448,348Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
17,7110Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
345,5681,780,674Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
144$20.00$2.9K1,821,483Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
150,802154,268Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
150,8020Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
472,2961,430,637Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
472,2960Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
62$20.00$1.2K1,448,286Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,092,0800Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
43,901198,169Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
47,718245,887Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
40,953$0.07$2.9K1,821,627Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
5,6550Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
1,092,0801,117,184Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
20$20.00$400251,522Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
40,9530Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
5,655$0.07$396251,542Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
47,7180Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
944,0560Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
43,9010Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
345,5680Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
150,000$20.00$3.00M150,000Feb 9, 2021Feb 9, 2021View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
317,9220Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
713,2030Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
103,372$17.00$1.76M2,036,557Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
357,353$17.00$6.08M357,353Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
266,948266,948Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
14,275$17.00$242.7K281,223Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
364,1380Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
50,2820Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,933,1851,933,185Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
98,4840Feb 9, 2021Feb 9, 2021View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
3,245,0484,034,522Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
SALE
3,158,8510Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
185,526$19.00$3.52M185,526Jul 21, 2020Jul 21, 2020View →
ALXO
ALX ONCOLOGY HOLDINGS INC
PURCHASE
789,474$19.00$15.00M789,474Jul 21, 2020Jul 21, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
133$19.50$2.6K168,165Mar 9, 2020Mar 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
48$19.50$936375,880Mar 9, 2020Mar 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
347$19.50$6.8K2,722,045Mar 9, 2020Mar 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,451$21.40$31.1K2,722,392Feb 10, 2020Feb 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
200$21.40$4.3K375,928Feb 10, 2020Feb 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
5,904$21.40$126.3K168,298Feb 10, 2020Feb 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
4,614$22.00$101.5K174,202Feb 7, 2020Feb 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,134$22.00$24.9K2,723,843Feb 7, 2020Feb 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
157$22.00$3.5K376,128Feb 7, 2020Feb 11, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
357$22.80$8.1K376,285Feb 4, 2020Feb 6, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
2,584$22.80$58.9K2,724,977Feb 4, 2020Feb 6, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
10,519$22.80$239.8K178,816Feb 4, 2020Feb 6, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
143$21.70$3.1K376,642Jan 31, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
4,220$21.70$91.6K189,335Jan 31, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,037$21.70$22.5K2,727,561Jan 31, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
201$22.10$4.4K376,785Jan 30, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,459$22.10$32.2K2,728,598Jan 30, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
5,940$22.10$131.3K193,555Jan 30, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
10,878$22.20$241.5K199,495Jan 29, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
2,673$22.20$59.3K2,730,057Jan 29, 2020Jan 31, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
369$22.20$8.2K376,986Jan 29, 2020Jan 31, 2020View →
Other insiders · TERN
Loading peer insiders…
About this filer
CIK 0001728970
ROLE
10% Owner
PRIMARY
TERN
COMPANIES
7
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001728970DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback